Drug-labels.com

Fluzone (Sanofi Pasteur): Uses, Side Effects and Dosage

Status:
Current status: Cancelled Pre Market Facts
Strength:
15 mcg / 15 mcg / 15 mcg, 7.5 mcg / 7.5 mcg / 7.5 mcg

Patient Medication Information: uses, side effects, how to take - Fluzone (Sanofi Pasteur)

What the vaccine is used for:

FLUZONE® is a vaccine used to prevent influenza. Influenza (or flu) is an infection caused by the influenza virus.

This vaccine may be given to adults and children 6 months of age and older.

Flu symptoms can include fever, headache, muscle pain, runny nose, sore throat, extreme tiredness and cough. Some people get much sicker.

The influenza virus spreads when a person who has the flu coughs or sneezes into the air. Small droplets of the flu virus stay in the air for a short time then fall onto surfaces nearby. You can get the flu by:

  • breathing in these droplets through your nose or mouth.
  • the droplets landing directly on your eyes.
  • touching the hands of a person who has the flu and then touching your eyes, nose or mouth.
  • touching surfaces that have been contaminated with flu virus and then touching your eyes, nose or mouth.

What it does:

FLUZONE® causes your body to produce its own protection against influenza virus. After you get a flu shot, your immune system produces antibodies against the strains of virus that are in the vaccine. The antibodies are effective for the duration of the flu season. When you are exposed to the virus, the

antibodies will help to keep you from getting sick. If you do get the flu, you may not be as sick.

When it should not be used:

FLUZONE® should not be used in the following situations:

Do not give FLUZONE® to anyone who has ever had a severe allergic reaction to:

  • egg or egg products
  • any component of FLUZONE® or its container.

What the medicinal ingredient is:

Each 0.5 mL dose of FLUZONE® contains killed split viruses from three strains of influenza virus for the 2014-2015 season. The viruses in FLUZONE® are:

  • A/California/7/2009 (H1N1) pdm09-like strain

    • A/Texas/50/2012 (H3N2)-like strain
  • B/Massachusetts/2/2012-like strain.

What the important nonmedicinal ingredients are:

Thimerosal (only in the multidose vial), sodium phosphate-buffered, isotonic sodium chloride solution, formaldehyde, Triton® X-100, sucrose and gelatin.

What dosage forms it comes in:

Individual doses in a vial or a prefilled syringe, or a vial that contains enough vaccine for many doses.

WARNINGS AND PRECAUTIONS

FLUZONE® will only protect against the strains of flu virus contained in the vaccine or those that are closely related. FLUZONE® will not protect against any other strains of flu virus.

If you have any of the following conditions, talk to your doctor, nurse or pharmacist BEFORE you use FLUZONE®:

  • Diseases of the immune system or who are having treatment that affects the immune system. The vaccine may provide you with a lower level of protection than it does for people with healthy immune systems.

IMPORTANT: PLEASE READ

  • A bleeding disorder or taking blood-thinning medications. Tell the person giving you the injection about your condition. There is a risk of excessive bleeding at the injection site if it is not done carefully.
  • Pregnant or breast-feeding women. It is important that you understand the risks and benefits of vaccination. FLUZONE® should be given to a pregnant or nursing woman only if it is clearly needed. Tell the person giving you the injection if you are pregnant or breast-feeding.

  • Allergy to egg protein or any component of the vaccine or the container.
  • Fever or serious illness. Wait until the person is better before giving the flu shot. A person who has a mild illness (such as a mild cold) may have the flu shot. Ask your doctor, nurse or pharmacist for advice.
  • A history of Guillain-Barré syndrome (GBS) within 6 weeks of a previous influenza vaccination.

The use of FLUZONE® in infants under 6 months of age is not recommended.

As with all vaccines, FLUZONE® does not protect 100% of people immunized.

INTERACTIONS WITH THIS VACCINE

FLUZONE® must not be mixed with other vaccines or medicinal products in the same syringe.

PROPER USE OF THIS VACCINE

Usual dose:

For children 6 - 35 months - recommended dose is 0.25 mL or 0.5 mL. The National Advisory Committee on Immunization (NACI) recommends that children 6 to 35 months of age should be given a full dose (0.5 mL).

For persons 3 years or older - recommended dose is 0.5 mL.

Children under 9 years of age who have not received a previous vaccination - 2 doses are required 4 weeks apart. The second dose is not needed if the child received one or more doses of influenza vaccine in a previous season.

For adults and children older than 1 year, inject the vaccine into the deltoid (shoulder) muscle.

For infants and children less than 1 year inject the vaccine into the mid-thigh muscle.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

If a child’s second dose is missed, it can be given at any time.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

A vaccine, like any medicine, may cause serious problems, such as severe allergic reactions. The risk of FLUZONE® causing serious harm is extremely small. The small risks associated with FLUZONE® are much less than the risks associated with getting the disease against which it protects.

The flu vaccine cannot cause influenza because it does not contain any live virus. The most common side effect is soreness where you got the injection. It may last a couple of days. You might also notice fever, fatigue and muscle aches within 6 to 12 hours after your shot. These side effects may last a day or two.

Severe allergic reactions to the flu shots are very rare. A very rare but possible side effect of influenza vaccination is Guillain-Barré syndrome (GBS). This is an autoimmune disease that attacks the nervous system. GBS causes weakness and abnormal sensations. Most patients recover fully. This is not a complete list of side effects. Talk to your doctor or nurse before receiving FLUZONE®.

Tell your doctor, nurse or pharmacist as soon as possible if you do not feel well after having FLUZONE®.

For any unexpected effects after having FLUZONE®, contact your doctor, nurse or pharmacist.

HOW TO STORE IT

Store in a refrigerator at 2° to 8°C (35° to 46°F). Do not freeze. Discard product if it has been exposed to freezing. Protect from light.

Do not use vaccine after expiration date.

Discard the multidose vials of FLUZONE® 28 days after first use.

Keep FLUZONE® out of children’s reach.

REPORTING SUSPECTED SIDE EFFECTS

To monitor vaccine safety, the Public Health Agency of Canada collects information on serious and unexpected case reports on adverse events following immunization.

For Health Care Professionals:

If a patient experiences an adverse event following immunization, please complete the appropriate Adverse Events Following Immunization (AEFI) Form and send it to your local Health Unit in your province/territory.

For the General Public:

Should you experience an adverse event following immunization, please ask your doctor, nurse, or pharmacist to complete the Adverse Events Following Immunization (AEFI) Form.

If you have any questions or have difficulties contacting your local health unit, please contact the Vaccine Safety Section at the Public Health Agency of Canada:

By toll-free telephone: 1-866-844-0018 By toll-free fax: 1-866-844-5931 Web: http://www.phac-aspc.gc.ca/im/vs-sv/index-eng.php By regular mail:

The Public Health Agency of Canada Vaccine Safety Section

130 Colonnade Road

Address Locator: 6502A

Ottawa, ON K1A 0K9

NOTE: Should you require information related to the management of the side effect, please contact your health care provider before notifying the Public Health Agency of Canada. The Public Health Agency of Canada does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found at: www.sanofipasteur.ca or by contacting the vaccine producer, Sanofi Pasteur Limited, 1755 Steeles Avenue West, Toronto, Ontario, M2R 3T4.

Phone: 1-888-621-1146 or 416-667-2779. Business Hours: 8 a.m. to 5 p.m., Eastern Time, Monday to Friday.

R26-0814 Canada

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02365715

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Fluzone (Sanofi Pasteur)

DIN 02365715, 02365693
Schedule(s) SCHEDULE D
Active ingredient(s) Haemagglutinin-strain a (h1n1), Haemagglutinin-strain a (h3n2), Haemagglutinin-strain b
Dosage form(s) Suspension
Route(s) of administration Intramuscular
Drug class (WHO ATC)
  1. J Antiinfectives for systemic use
    1. J07 Vaccines
      1. J07B Viral vaccines
        1. J07BB Influenza vaccines
          1. J07BB02 Influenza, inactivated, split virus or surface antigen
Company SANOFI PASTEUR INC
Current status Cancelled Pre Market
Current status date December 21, 2016
Strengths and forms
DIN Strength Dosage form(s) Current status
02365715 15 MCG / 15 MCG / 15 MCG Suspension Cancelled Pre Market December 21, 2016
02365693 7.5 MCG / 7.5 MCG / 7.5 MCG Suspension Cancelled Pre Market December 21, 2016

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.